Shorter-duration therapy using vincristine, dactinomycin, and lower-dose cyclophosphamide with or without radiotherapy for patients with newly diagnosed low-risk rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
暂无分享,去创建一个
James R. Anderson | J. Meza | A. Pappo | D. Hawkins | W. Meyer | J. Breneman | T. Cripe | D. Parham | A. Hayes-Jordan | D. Walterhouse